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INVESTIGATION OF CRISPR-INDUCED MUTANTS OF THE PUTATIVE 
SCRAMBLASE GENE CG32579IN NURSE CELL CLEARANCE IN THE 
DROSOPHILA OVARY 
 
MARIJA STOJANOVA 
ABSTRACT 
Programmed cell death is vital for maintaining an organism’s survival and health and 
ensuring normal development. Cell corpses are engulfed by either professional 
phagocytes, like macrophages, or nonprofessional phagocytes. In the Drosophila ovary, 
stretch follicle cells act as nonprofessional phagocytes to clear nurse cell corpses from 
egg chambers during oogenesis. In mammalian systems, scramblases such as TMEM16F 
and Xkr8 are responsible for exposing phosphatidylserine to the cell exterior of dying 
cells, producing an “eat me” signal. This project explored the effects of mutagenesis via 
CRISPR/Cas9 editing on the Drosophila Xkr8 ortholog, CG32579, by observing egg 
chambers of CG32579 single mutants, double mutants with the TMEM16 family member 
subdued, and subdued mutants alone. The single CG32579 mutants that were observed 
did not show a phenotype related to nurse cell clearance, and the subdued and double 
mutants showed a weak persisting nuclei phenotype.  These findings suggest that 
CG32579 and subdued do not play major roles in nurse cell clearance in the Drosophila 
ovary. 
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CHAPTER ONE 
Introduction 
 
1.1 Project Rationale  
This project utilizes Drosophila melanogaster as a model organism to study the 
effects of mutagenesis in the scramblase CG32579 on the molecular mechanisms of cell 
death and engulfment via phosphatidylserine exposure. Drosophila is an excellent model 
organism due to their short lifespan, rapid rate of reproduction, and high level of 
similarity with humans in disease causing genes. CG32579 is the ortholog of the human 
gene Xkr8; therefore, discoveries made using CG32579 could potentially be applicable to 
human disease studies. 
1.2 Programmed Cell Death  
Programmed cell death is a process necessary for regulation of growth and 
development in living organisms. There are five main functions of PCD: sculpting bodily 
structures like limbs during embryogenesis, eliminating unnecessary bodily structures, 
keeping cell numbers in check, destroying damaged cells, and producing differentiated 
cells that do not contain organelles (Jacobson et al. 1997). Unlike accidental cell death, 
which occurs suddenly in response to cell damage or pathogenic conditions, programmed 
cell death is completely physiological and proceeds in an organized and mechanistic 
manner, is transcriptionally regulated and follows signaling pathways. There are three 
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major types of programmed cell death: apoptosis, necrosis, and autophagy-dependent cell 
death (Fuchs & Steller 2015). 
1.2.1 Apoptosis Overview and Mechanism 
Apoptosis is the most common type of developmental PCD, occurring in response 
to both internal causes such as cell damage and external causes such as an inhospitable 
environment. There are universal morphological characteristics associated with apoptosis, 
such as a condensed nucleus and cytoplasm, nuclear fragmentation, and the formation of 
apoptotic bodies (Kerr et al. 1972). These apoptotic bodies are then phagocytosed by 
macrophages or other cells and finally degraded by lysosomes. The process of apoptosis 
is facilitated by a class of proteases called caspases. Although the exact number of 
caspases varies among species, most contain two types of caspases: initiator and executor 
caspases. Initiator caspases activate other caspases and initiate the mechanisms of 
apoptosis, as their name suggests. Executor caspases cleave cellular proteins throughout 
apoptosis (Lamkanfi et al. 2002). Caspase activity triggers the exposure of 
phosphatidylserine on the exterior of the cell membrane (Suzuki et al. 2016). Apoptotic 
cell death proceeds without impacting the surrounding tissue, making it ideal for a 
frequent process like programmed cell death.  
1.2.2 Apoptosis in Drosophila 
For apoptosis to proceed, a class of proteins called inhibitor of apoptosis proteins 
(IAPs) must be inactivated. In Drosophila, the major IAP is Drosophila IAP1 (Diap1). 
The human orthologue is X-linked IAP (XIAP). These proteins are inhibited by Reaper, 
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Hid, and Grim in Drosophila and SMAC and HTRA2 in humans. Once IAPs have been 
inactivated, the executioner caspases are free to carry out their function. 
Apoptosis is widely used in Drosophila as a PCD mechanism; glia, neurons, 
imaginal disc cells and ovaries all use apoptosis in some capacity for PCD. 
1.2.3 Autophagy-dependent Cell Death  
During autophagy, cytoplasmic components are encased in vesicles called 
autophagosomes. The autophagosomes fuse with lysosomes and their contents are 
degraded. Autophagy relies on evolutionarily conserved autophagy related genes referred 
to as Atg genes. Inactivation of these genes leads to accelerated cell death, suggesting that 
their function in autophagy is to promote overall cellular and organismal survival (Shen 
et al. 2012). However, autophagy can also lead to cell death, such as during PCD of the 
Drosophila midgut and salivary glands. Interestingly, Draper, an engulfment receptor, is 
required to induce autophagy in Drosophila in the salivary glands (McPhee et al. 2010). 
1.2.4 Necrosis 
The best understood form of necrosis is mammalian necroptosis, a form of PCD 
resulting when caspases are inhibited, relying instead on RIPK1 (Degterev et al. 2005). It 
is characterized by nuclear condensation, organelle swelling, and rupturing of the plasma 
membrane. In the canonical NF-κB pathway, tumor necrosis factor (TNF) binding to 
TNFR1 recruits TRADD, RIPK1, TRAF2, TRAF5, cIAP1 and cIAP2 to form complex 1. 
cIAP1 and cIAP2 are involved in RIPK1 ubiquitylation, which activates IKK. IKK then 
leads to IκBα degradation, which ends its inhibition of NF-κB. Once active, NF-κB 
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translocates to the nucleus and drives transcription of the genes coding for A20 and FLIP. 
Together, these two proteins cause RIPK1 disassociation from complex 1 and lead to the 
formation of the death-inducing signaling complex (DISC), containing RIPK1, RIPK3, 
TRADD, FADD, FLIP, and caspase 8. This complex activates caspase 8 and cell death 
proceeds. If caspase 8 is inactivated, RIPK1 and RIPK3 associate together and form the 
necrosome after autophosphorylation and transphosphorylation. RIPK3 phosphorylation 
leads to MLKL recruitment and necroptosis initiation. None of the key necroptosis 
related genes have been identified in Drosophila yet. 
1.2.5 PCD in Humans  
PCD plays many vital roles throughout the human lifespan, from ensuring normal 
growth and development, to eliminating abnormal cells. Its earliest role is during 
embryogenesis with neural tube formation (Glücksmann 1951). In humans, PCD is 
responsible for proper structure formation, sculpting digits by eliminating extraneous 
cells, as well as ridding the body of unnecessary structures. For instance, the Müllerian 
duct, which forms female reproductive structures, is not needed in males, just as the 
Wolffian duct, which forms male reproductive structures, is not needed in females 
(Jacobson et al. 1997). PCD plays a large role in nervous system development, regulating 
the number of neurons and oligodendrocytes to match the number of target cells they 
innervate or axons they myelinate respectively (Barde 1989; Barres et al. 1992). Aside 
from normal development, PCD also recognizes damaged cells and destroys them before 
further harm is done, such as those with damaged DNA using the p53 pathway to prevent 
tumor formation (Clarke et al. 1993; Lowe et al. 1993). Damaged T and B lymphocytes, 
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lacking functional antigen receptors, would be detrimental to the immune system and are 
thus eliminated via PCD.  
1.2.6 PCD in Drosophila  
PCD is crucial to normal Drosophila growth and development. The Drosophila 
central nervous system, reproductive organs, salivary glands, and midgut all undergo 
PCD at certain key points during the life cycle (Yalonetskaya et al. 2018).  
1.3 Drosophila Ovary Overview 
Drosophila females have two ovaries organized into 15-20 ovarioles. Each 
ovariole contains the germarium, comprised of germline and somatic stem cells. 
Throughout the 14 stages of oogenesis, two or three germline stem cells divide 
asymmetrically to produce 15 nurse cells and 1 oocyte (Figure 1.3).  These nurse cells 
support the developing oocyte by providing necessary mRNA, organelles, and proteins. 
Eventually, these contents are “dumped” into the oocyte and the empty nurse cells are 
cleared (Spradling 1993). 
1.3.1 Drosophila Ovary Development and Cell Death  
PCD is integral to egg chamber maturation. Maturation of these egg chambers 
occurs over 14 discrete stages, recognizable due to their morphological differences. Stage 
14 results in one fully developed egg (Spradling 1993). During late oogenesis, the nurse 
cells dump their cytoplasm and other contents into the egg and die (Guild et al. 1997; 
Buszczak & Cooley 2000). The cell corpses are cleared by nonprofessional phagocytes 
(Timmons et al. 2016). Nurse cell death occurs over several stages of oogenesis. Initially, 
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their nuclear membranes are permeabilized at the end of stage 10 (Cooley et al. 1992). 
Next, dumping happens during stage 10B-11, with a cytoplasmic actin network 
surrounding each nurse cell nucleus (Buszczak & Cooley 2000). Dumping ends by stage 
12. The nurse cell nuclei condense during stages 12-14. Meanwhile, stretch follicle cells 
surround the nurse cells during stages 11 and 12. The engulfment receptor Draper 
increases on stretch follicle membranes during stages 11 and 12, at which point acidic 
vesicles are also present and JNK signaling is activated. At stage 13, nurse cell 
acidification is complete and their DNA is fragmented. Clearance of the nurse cell 
corpses is completed by stage 14. Nurse cell death is thought to proceed via phagoptosis, 
a form of cell death dependent on phagocytic machinery (Timmons et al. 2016). Cell 
death can also spontaneously occur via apoptosis during the middle stages of oogenesis 
(midstage) (Spradling 1993). Egg chambers undergoing midstage death can be 
recognized by their condensed chromatin in nurse cell nuclei. 
1.4 Phospholipids in the Cell Membrane   
The cell membrane is composed of various types of phospholipids arranged in a 
bilayer: the external layer, with the phospholipid heads facing the extracellular 
environment, and the internal layer, or inner leaflet, facing the cytoplasm. These 
phospholipids, including phosphatidylcholine, phosphatidylserine, sphingomyelin, and 
phosphatidylethanolamine, are asymmetrically arranged within the plasma membrane. 
Phosphatidylcholine and sphingomyelin are primarily found in the outer layer, and 
phosphatidylserine and phosphatidylethanolamine are primarily in the inner layer. In 
healthy cells, phosphatidylserine is solely located in the inner layer of the cell membrane. 
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Its exposure on the outer layer acts as an “eat me” signal during cell death and leads to 
phagocytic engulfment (Verhoven et al. 1995). 
1.5 Calcium Activated Scramblases  
To maintain proper phospholipid localization, scramblases can move 
phospholipids from one cell membrane layer to the other bidirectionally. These enzymes 
move specific target phospholipids from one side of the plasma membrane to the other. 
Usually ATP-driven aminophospholipid translocases ensure that phosphatidylserine is 
kept on the cytosolic side of the plasma membrane. When phosphatidylserine needs to be 
exposed to the cell exterior, calcium activated scramblases are activated by increased 
intracellular Ca2+ and move phosphatidylserine to the outer layer of the cell membrane. 
One of the most important instances of this PS translocation is during apoptosis (Fadok et 
al. 1992). 
1.6 Flippases and Floppases 
 Flippases, or ATP-dependent aminophospholipid translocases, move 
phospholipids from the extracellular side of the plasma membrane to the intracellular 
side. This is important for maintaining cell membrane symmetry and keeping 
phosphatidylserine and phosphatidylethanolamine on the inner side of the plasma 
membrane in healthy cells. ATP11A and ATP11C, which are part of the P4-ATPase 
family of flippases, perform this function for phosphatidylserine. Unlike calcium 
activated scramblases, these flippases are inhibited by increasing intracellular calcium 
concentration (Segawa et al. 2016). Floppases, on the other hand, translocate 
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phospholipids from the intracellular side of the plasma membrane to the extracellular 
side. 
1.6.1 XKR8  
XKR8 is a mammalian 401 amino acid protein with 6 transmembrane domains 
and cytosolic C- and N-termini (Figure 1.4). Its C-terminus region has a recognition 
sequence for caspase 3, allowing the caspase to cleave XKR8 and cause it to become 
functional. XKR8 flips phosphatidylserine and phosphatidylethanolamine from the inner 
to the outer side of the plasma membrane, acting as a floppase, and phosphatidylcholine 
and sphingomyelin from the outer to the inner side, acting as a flippase. Its floppase 
activity of phosphatidylserine is an important step in the apoptosis pathway, acting as an 
“eat me” signal for macrophages to come and perform phagocytosis of the apoptotic cell 
(Fadok et al. 1992; Suzuki et al. 2013a). 
1.6.2 TMEM16  
TMEM16 is a family of calcium-activated transmembrane proteins composed of 
10 different proteins in mammals: TMEM16A, TMEM16B, TMEM16C, TMEM16D, 
TMEM16E, TMEM16F, TMEM16G, TMEM16H, TMEM16J, and TMEM16K (Galindo 
& Vacquier 2005). Of these proteins, TMEM16A and TMEM16B function as calcium-
activated chloride channels (Caputo et al. 2008; Schroeder et al. 2008; Yang et al. 2008; 
Pifferi et al. 2009) and the remainder function as calcium-activated phospholipid 
scramblases (Suzuki et al. 2013b). Each protein is made up of 8 transmembrane segments 
and has cytosolic N- and C-termini (Galietta 2009). The transmembrane sequences of 
TMEM16 proteins are the most highly conserved, with variable sequences present in the 
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cytosolic and extracellular segments. Ion permeability is dependent on certain TMEM16 
proteins which are overexpressed in human cancers; further study could elucidate 
mechanisms of cancer proliferation or resistance and potentially lead to the development 
of treatments targeting TMEM16 proteins. 
1.6.3 TMEM16F 
TMEM16F is a calcium-activated scramblase whose function is to flip 
phosphatidylserine from the inner leaflet of the plasma membrane to the outer (Suzuki et 
al. 2010.; Yang et al. 2012). The scramblase activity in TMEM16F is mediated by a 35 
amino acid scrambling domain (SCRD) containing specific amino acids involved in PS 
externalization, whose substitution negatively impacts the ability of TMEM16F to expose 
PS, but not other phospholipids (Gyobu et al. 2017). 
1.6.4 Subdued 
 Subdued is the Drosophila ortholog of the mammalian protein TMEM16F. Also 
known as CG16718, subdued was so named due to the fact that when its mRNA is 
knocked out with RNAi, Drosophila have a higher rate of infection with Serratia 
marcescens, and consequently increased mortality (Wong et al. 2013). The gene subdued 
codes for a calcium-activated scramblase expressed throughout the fly body. Like its 
categorization suggests, Subdued selectively allows chloride ions to cross the plasma 
membrane when activated by intracellular calcium concentrations of at least 20 μM 
(Wong et al. 2013). Subdued is thought to play a role in immunity, with RNAi 
demonstrating that the gut is particularly susceptible to S. marcescens infection. More 
relevant to this project, subdued mutations were found to reduce nurse cell death and 
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clearance in the Drosophila ovary during late stage oogenesis (J. Peterson personal 
communication). The phenotype of subdued mutants was weak suggesting another gene 
might act redundantly with subdued during nurse cell death. 
1.6.5 CG32579 
CG32579 is the Drosophila ortholog of XKR8. The gene is 1296 nucleotides long 
and located on the X chromosome. (http://flybase.org/reports/FBgn0052579) Much is 
still unknown about its exact function and role in the Drosophila apoptotic pathway, such 
as whether there is a phenotype associated with loss of CG32579 and how specific the 
protein sequence needs to be for full enzymatic activity. To study this phenomenon, the 
first exon of CG32579 was edited using CRISPR/Cas9 to see whether this would 
introduce a null mutation and impact protein function and have phenotypic consequences 
in the fly. Since Subdued and CG32579 both are predicted to function as scramblases, we 
additionally wanted to test whether double mutants have any phenotypic differences from 
either single mutants or control w1118 flies.  These findings would give insight into 
whether these two proteins interact or function within the same molecular pathway. 
Functional redundancy between scramblase genes has been recently described in C. 
elegans (Li et al. 2015). 
1.7 Drosophila Genetics  
1.7.1 Drosophila Chromosomes 
The Drosophila genome is organized into 4 chromosomes. Chromosomes 1-3 
contain over 99% of the genome and therefore chromosome 4 is not generally considered 
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when creating fly crosses. Chromosome 1 is the sex chromosome and can be either X or 
Y. Two X chromosomes denote female flies and an X chromosome and a Y chromosome 
denote male. (Ashburner 1989) 
1.7.2 Drosophila Markers 
Certain genes with visible phenotypes, such as white eye color, can be used as 
markers in conjunction with other genes of interest, which may not necessarily exhibit 
superficial phenotypes. Crosses can be engineered in a manner that lead to the gene with 
the visible phenotype being inherited along with the gene of interest; the former is 
referred to as a marker. Marker genes and special chromosomes utilized in this project 
include white, Curly-O (CyO), inflated (If), stubble (Sb), TM6B, MKRS, and TM2 
(Markstein 2018). 
1.7.3 Drosophila Balancer Chromosomes 
Balancer chromosomes contain an inversion in the order of genes present on the 
chromosome, preventing recombination with the homologous chromosome during 
meiosis. They carry a dominant visible marker, making flies with balancers easily 
recognizable under the microscope, and are recessive lethal; Drosophila require a copy of 
the non-balancer homologous chromosome alongside the balancer to be viable. These 
traits make balancers useful for maintaining genetic mutants in mutation screenings, as in 
this project (Ashburner 1989). 
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1.8 CRISPR/Cas9 Overview and Mechanism 
CRISPR/Cas is a gene editing process originally used by bacteria to recognize 
invading viruses and neutralize them. CRISPR stands for clustered repeated interspersed 
short palindromic repeats, which are 25-50 nucleotide sequences repeated within in the 
bacterial DNA (Mojica et al. 2000). These sequences alternate with spacers, which are 
unique sequences 21-37 nucleotides in length (Jansen et al. 2002). Spacers are taken up 
from viruses (Bolotin et al. 2005) and confer viral immunity to bacteria by allowing them 
to recognize a future infection by the same virus (Barrangou et al. 2007). Each time a 
new virus is encountered, a new spacer is introduced to that bacteria’s DNA, increasing 
its immunity. Cas, or CRISPR-associated, are proteins coded by cas genes which bind to 
specific DNA sequences (Mojica et al. 2000; Jansen et al. 2002) by recognizing short 
RNA sequences transcribed from the spacers (Tang et al. 2004). Initially, these sequences 
are termed pre-crRNA and require further processing before being functional.  
There are 6 different types of CRISPR systems as categorized by which Cas 
proteins execute the various functions associated with crRNA (Makarova et al. 2015; 
Shmakov et al. 2015). The functions are grouped into expression (pre-crRNA 
processing), interference (target binding and cleavage), adaptation (spacer insertion), and 
ancillary (regulatory and miscellaneous) (Makarova et al. 2015). CRISPR/Cas systems 
are divided into two classes, Class 1 and class 2, with each class containing 3 types. Class 
1 contains types I, III, and IV, while Class 2 contains types II, V, and VI. Of these 6 
types, the most used by scientists is type II due to its overall simplicity. In type II, pre-
crRNA undergoes processing by trans-activating CRISPR RNA (tracRNA) and cleavage 
 13 
by RNase III to become functional crRNA containing a spacer and a repeat (Brouns et al. 
2008; Deltcheva et al. 2011). 
Once mature, the tracRNA and crRNA hybridize on the repeat section in the 
crRNA, while the spacer hybridizes with the complementary 20 nucleotide section of the 
viral DNA. Cas9, a DNA endonuclease, then cleaves the DNA; its RuvC and HNH 
domains cleaving the target and non-target DNA strands respectively (Gasiunas et al. 
2012; Makarova et al. 2015) creating a double stranded break with a blunt end 3 
nucleotides away from the PAM (Gasiunas et al. 2012) which is then repaired with 
nonhomologous end joining or homology directed repair (Sung & Klein 2006; Lieber 
2010). Conservation of certain amino acids in these endonuclease domains is necessary 
for their function (Sapranauskas et al. 2011). For recognition by crRNA to occur, a 
protospacer adjacent motif (PAM) must be present downstream of the target DNA 
sequence (Horvath et al. 2008). This sequence varies among different bacterial species, 
but is conserved within a species (Sapranauskas et al. 2011). Once a DNA sequence has 
been recognized, crRNA binds to the sequence and the nuclease domains in Cas9 cleave 
the sequence (Jinek et al. 2012). Cas1, Cas2, and Cas4 carry out spacer insertion, with the 
latter protein also playing a regulatory role (Brouns et al. 2008; Deltcheva et al. 2011). 
Since Cas9 cleavage specificity is determined by the crRNA (Gasiunas et al. 2012), this 
system can be used in other organisms to edit their DNA (Cong et al. 2013) by inserting 
portions of DNA carrying a desired sequence (Jiang & Doudna 2017). In these 
applications, tracRNA and crRNA can be combined to one longer RNA transcript, 
referred to as single guide RNA (sgRNA) (Jinek et al. 2012). 
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1.8.1 CRISPR/Cas9 utilization and justification  
By changing the sgRNA sequence used, CRISPR/Cas9 can be used to target a 
variety of sequences in order to program genes of interest or study the effects of 
mutagenesis (Cong et al. 2013). The development of sgRNA libraries has led to genome 
wide CRISPR screenings using one sgRNA sequence to target multiple loci (Cong et al. 
2013) as well as implementation in gene manipulation techniques such as activation, 
repression, expression, or regulation (Dominguez et al. 2016). CRISPR/Cas9 is a 
valuable tool in the search for drug targets and in the study of disease-causing genes 
(Shalem et al. 2015). During this project, CRISPR/Cas9 was used as a mutagenic agent in 
order to study the function of CG32579 in Drosophila melanogaster by introducing a null 
mutation in CG32579.  
1.9 Thesis Rationale and Summary 
 In this thesis, I explored the effects of CRISPR/Cas9 induced mutagenesis on 
CG32579; specifically observing whether any phenotype related to nurse cell clearance 
resulted. I also observed the effect of doubly mutated CG32579 and subdued in 
Drosophila nurse cell clearance. Both CG32579 and Subdued expose PS to the cell 
exterior, which initiates the apoptotic pathway by serving as an “eat me” signal (see 
sections 1.6.1, 1.6.3, 1.6.4, and 1.6.5). By mutating both genes, any resulting change in 
the corresponding proteins could be observed, and any additive effect of the mutations 
could be quantified by comparing to the single mutants for CG32579 and subdued. 
Knowing whether these mutations produce an additive effect in CG32579 and Subdued 
could give insight into the apoptotic signaling pathways in which both of these proteins 
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are involved. To perform these experiments and analysis, CRISPR/Cas9 editing was 
carried out in CG32579 and a mutant line, subduedKO11, was obtained. A series of crosses 
led to offspring that were doubly mutated in both genes. To observe the phenotypic effect 
of these mutations, ovaries from flies from the wild type w1118, each single mutant line 
obtained, and the double mutant line, were dissected, and nurse cell clearance was 
quantified by counting the number of persisting nurse cell nuclei remaining in stage 14 
egg chambers (in the wild type, none should remain). 
Figure 1.1 Roles of PCD in Development 
 
 
Four of the five main roles of PCD are shown here. On the top left, extraneous cells 
between the fingers are eliminated to sculpt the structure of the hand. On the top right, the 
tadpole’s entire tail is eliminated when it becomes a frog. On the bottom left, excess cells 
undergo PCD to maintain a single cell layer. On the bottom right, a damaged cell (shown 
in lighter green) undergoes PCD (adapted from Jacobson et al. 1997). 
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Figure 1.2 Macrophage engulfment of apoptotic cells 
 
Engulfment of apoptotic cells begins when apoptotic cells give a chemical signal (for 
instance, externalized phosphatidylserine). Macrophages can then recognize bind to this 
signal, triggering engulfment and subsequent degradation of apoptotic cells (Miles & 
Parmer 2014).   
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Figure 1.3 Drosophila Egg Chamber Development 
 
There are 14 stages of egg chamber development (oogenesis) in which germline stem 
cells divide to produce 1 egg and 15 nurse cells. The egg chamber is surrounded by a 
layer of follicle cells which begin to migrate away from the nurse cells during mid-
oogenesis. At stage 10B, nurse cells begin to be cleared by specialized follicle cells called 
stretch follicles. By stage 14, nurse cells are completely cleared in a wild type egg 
chamber and only the oocyte remains (Ables et al. 2016). 
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Figure 1.4 Transmembrane protein structures of XKR8 and TMEM16F. 
 
XKR8 and TMEM16F are the human orthologs of the Drosophila proteins CG32579 and 
Subdued respectively. This diagram shows their transmembrane structures, numbering 
how many sections each has crossing the cell membrane (Segawa et al. 2014). 
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Figure 1.5 CRISPR/Cas proteins organized by type. 
 
Each CRISPR/Cas type utilized a unique combination of proteins to perform the spacer 
acquisition, crRNA processing, crRNP assembly and surveillance, and target degradation 
functions. Here, they are organized by CRISPR/Cas type and function (van der Oost et al. 
2014).  
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Figure 1.6 CRISPR/Cas mechanism for each type of CRISPR/Cas 
 
Each type of CRISPR/Cas has a different mechanism of carrying out target scanning 
through degradation, which are illustrated here (van der Oost et al. 2014).   
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CHAPTER TWO 
Materials and Methods 
 
2.1 Fly Maintenance  
Mutant fly lines for CG32579 were produced using CRISPR. subduedKO11 fly 
lines were obtained from Susan Younger. Fly lines containing CyO, TM2 and T(2:3)apXa 
were obtained from O. Papoulas. All other fly lines were obtained from Bloomington 
Stock Center. Flies were raised on standard molasses/cornmeal food at 18°C unless 
otherwise indicated. All experiments were conducted with adult flies unless specified.  
2.2 CRISPR/Cas9 Editing 
Drosophila melanogaster vasa-Cas9 embryos were injected with two 23 
nucleotide guide RNAs designed by Ben Housden to target the first exon in CG32579. 
Injections were carried out by BestGene Inc. The sequences used were 
CCTGGCGTACGTGTACTGGATGG and CGAGATCGGCCCCATCATAAGGG. 
2.3 DNA Extraction  
DNA was obtained from the fly lines using the squish fly method (adapted from 
Gloor et al. 1993 by G. Dietzl). 1 fly from each candidate line was anesthetized using 
CO2 gas and ground in a tube containing 50 μL squished fly buffer (for 10 mL, 9.61 mL 
deionized H2O, 100 μL Tris pH 8, 40 μL 0.25 M EDTA, and 250 μL 1 M NaCl) and 0.5 
μL 20 mg/mL proteinase K until the liquid in the tube appeared cloudy. These tubes were 
then incubated in a thermocycler at 37°C for 30 minutes and 95°C for 2 minutes. 
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Afterward, the tubes were centrifuged at 14000 rpm for 7 minutes to separate the 
extracted DNA from the body of the fly. Tubes were stored at 4°C and kept on ice when 
in use. 
2.4 PCR Protocol 
The extracted DNA was amplified using PCR with the primers 5’-
TTGTGTGTGGCTAGGGTGG-3’ and 5’-TCTCCGCCTGCTTGTCAT-3’ specific to 
CG32579. Three different protocols were used for DNA amplification. Initially, 2 μL of 
extracted DNA was amplified using 0.125 μL NEB Taq polymerase, 0.5 μL dNTP mix, 
0.5 μL each of the 10 μM forward and reverse primers, and 2.5 μL 10X NEB ThermoPol 
Buffer. Deionized H2O was added to yield a total volume of 25 μL. This solution was 
incubated in a thermocycler using the Taq program (Table 2.1). However, the Taq 
polymerase did not amplify the DNA well enough to show clear bands on the gels, so 
instead an alternate protocol using Phusion polymerase was implemented. For each DNA 
sample, 4 μL Phusion HiFi buffer, 0.4 μL dNTPs, 1 μL each of 10 μM forward and 
reverse primer, 0.5 μL Phusion polymerase, and 250 ng of DNA were added to enough 
dH2O to yield 20 μL final volume. DNA concentration was calculated using NanoDrop 
on the Nucleic Acids setting. The NanoDrop apparatus was blanked using 1 μL of squish 
fly buffer and then 1 μL of DNA sample was tested to determine its DNA concentration 
via absorptivity. This concentration was used to determine the volume of DNA added to 
the PCR solution. The resulting solution was incubated in a thermocycler using the 
Phusion program (Table 2.2). A third PCR protocol using LongAmp TAQ polymerase 
was used to obtain clearer gel images. For one 25 μL aliquot, 5 μL 5X LongAmp Taq 
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reaction buffer, 0.75 μL 10 mM dNTPs, 1 μL each of forward and reverse 30 μM 
primers, 2 μL extracted DNA, 1 μL LongAmp Taq, and 14,25 μL dH20 were used. The 
thermocycler incubation program is shown in Table 2.3. Amplified DNA was stored at 
4°C and kept on ice when in use. 
2.5 Gel Electrophoresis Gel Protocol 
To create the gel used for gel electrophoresis, 50 mL of 1X TAE buffer were 
added to 0.75 g agarose and microwaved until combined but not bubbling. The hot 
agarose solution was poured into a mold, and a comb was placed on one end to create the 
desired number of wells in the gel. The gel was then allowed to cool and solidify. 
Approximately 250 mL of 1X TAE buffer was used to fill the electrophoresis unit to the 
fill line before running the gel. Gels were run at 85V until the leading band was at least 
three-quarters of the way down the gel from the loading wells. 
2.5.1 Gel Loading 
 For DNA amplified using Taq polymerase, 10 μL of reaction mixture containing 
the amplified DNA was mixed with 2 μL 6X blue/orange stain and mixed until 
homogeneous. For DNA amplified using Phusion polymerase, 5 μL of amplified DNA 
was mixed with 1 μL 6x blue/orange loading dye until homogeneous. The first well was 
always loaded with 5 μL of 100 base pair DNA ladder mixed with 1 μL 6X blue/orange 
loading dye. The fly line DF1 had previously been determined by Johnny Elguero to 
contain a mutation in the form of a deletion and w1118 was a wild type fly line. These two 
lines were thus used as a positive and negative control respectively in every gel.  
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2.5.2 Gel Staining and Analysis 
Gels were stained in a solution of 1 μL 1% ethidium bromide to 200 mL dH20 for 
30-45 minutes and destained in dH2O for 10 minutes. The gels were analyzed under UV 
for the deletion by comparing the location of the bands resulting from the amplified DNA 
samples with those of the positive and negative controls and photographed. 5 μL of 
10,000x SYBR Safe DNA gel stain was added to the TAE/agarose mixture before casting 
the gel. No destaining was necessary with this gel stain. 
2.6 Gene Sequencing 
2.6.1 DNA Purification 
DNA purification was performed using Qiagen QIAquick® PCR Purification Kit. 
Each 20 μL sample was treated with 100 μL of Buffer PB and centrifuged in a spin 
column to bind the DNA. The DNA was then washed with 0.75 mL of Buffer PE and 
centrifuged. Finally, the DNA was eluted with 15 μL of Buffer EB and centrifuged. Final 
DNA concentration was measured using the NanoDrop and diluted using deionized water 
as necessary to attain the DNA concentrations prescribed by GeneWiz. Eight total 
samples containing 10 μL of ~2 ng/μL purified DNA and 5 μL of either the forward or 
reverse primer were prepared. Samples were sent to GeneWiz for sequencing.  
2.6.2 Gene Sequence Alignment 
The gene sequence obtained by GeneWiz was then aligned with CG32579 using 
NCBI Blast. The accession number NM_167501.2 was used to obtain a transcript, which 
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was compared with each sequence acquired using both the forward and reverse primers 
for each fly line tested.  
2.7 Heterozygosity Screening  
20 crosses were created using males and females from the line PF5 to verify 
whether PF5 exhibited heterozygosity. DNA was extracted from these lines and analyzed 
in the same manner as the mutagenesis screening.  
2.7 Double Mutant Creation  
Double mutants were created using a series of 6 crosses to produce homozygous 
CG32579 and subdued mutants, which were examined for phenotypic differences. All 
crosses were conducted with virgin females and fly vials were stored at 25°C, unless 
virgin females were collected overnight, in which case the vials in question were stored at 
18°C. The methodology of the crosses is shown in Figure 2.2. 
2.8 Ovary Dissection 
Females were conditioned with wet yeast paste for 3 days and anesthetized with 
CO2 before dissection. Some females were starved on agar for an additional day before 
dissection. Dissection was performed on a depression slide with Drosophila Ringers 
solution. Using two pairs of forceps washed in 1X PBT, the posterior tip of the abdomen 
was gently pulled to remove the gut and then the ovaries. The ovaries were separated 
from any other Drosophila parts in the Ringers solution and then aspirated into 100 μL of 
1X PBS using a tip that was washed in 1X PBT. All tubes were kept on ice. 
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2.8.1 Ovary Fixing and Staining 
Ovaries were allowed to settle to the bottom of their tubes and then the PBS 
solution was aspirated out. 100 μL of FIX (84 μL of PBS and 16 μL 16% PFA) and 500 
μL of heptane were added to the same tubes. The tubes were shaken vigorously for 30 
seconds then incubated for 10 minutes in a rotator. Next, the tubes were spun for 3-5 
seconds in a mini centrifuge and the liquid was aspirated. The ovaries were washed 3 
times with 100 μL 1X PBT and agitated, spun, and aspirated between each wash to 
remove all heptane. After the final wash and aspiration steps have been completed, 100 
μL of DAPI/glycerol staining solution were added to the tubes. Tubes were stored in the 
dark at 4°C overnight. (adapted from Goldstein and Fyrburg 1994 by J. Peterson) 
2.8.2 Slide Assembly 
To assemble the slides, 20 μL of 70% glycerol in PBT was placed on a slide in the 
center of the slide. Ovaries were aspirated onto the slide with a pipet tip washed in 1X 
PBT. Once on the slide, ovaries were spread and dissected with metal insect pins in order 
to separate the individual egg chambers from each other and ensure that all egg chambers 
were clearly visible. A coverslip was mounted over the glycerol solution, and finished 
slides were kept in a slide book at 4°C. 
2.8.3 Slide Analysis 
Slides were analyzed at 10X magnification under the DAPI and green filters. 
Stage 14 egg chambers were counted and examined for the presence of persisting nurse 
cell nuclei near the dorsal appendage. The double mutant for CG32579 and subdued was 
 27 
also examined for a possible dying egg chamber phenotype during midstage oogenesis 
(stages 8-10).  
Figure 2.1 CRISPR/Cas Construct and Primer Targeting 
 
 
This figure shows a construct of where the gRNA sequences and primers would have 
targeted CG32579. The first gRNA sequence would have targeted the gene from 
nucleotide 217 to 239 and the second gRNA sequence would have targeted the gene from 
nucleotide 308 to 330. The forward primer targeted the gene from nucleotide 135 to 153, 
and the reverse primer targeted the gene from nucleotide 547 to 564. This depiction was 
created using SnapGene with the transcript for CG32579 indicated in 2.6.2. 
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Figure 2.2 Double Mutant Crosses 
                                                                   
 29 
        
This schematic depicts the series of fly crosses that were created in order to obtain a 
homozygous double mutant for subdued and CG32579. A1 crossed a male with white 
eyes (w) on the first chromosome, Inflated facets (If) and Curly-O (CyO) on the second, 
and the balancer TM6B and MKRS with a female containing PG150 (white+) and the 
balancer FM7 on the first chromosome. The female progeny containing the FM7 balancer 
and w on the first chromosome, CyO on the second, and TM6B on the third were taken 
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and crossed with males from the subduedKO11 line containing w on the on the first 
chromosome and two copies of subdued on the third (A2). B1 crossed a male with yw on 
the first chromosome, CyO on the second, and TM2 on the third from the awesome stock 
(apXa) with a female containing two copies of mutated CG32579 from the line DF1. The 
male progeny of the B1 cross containing a copy of the mutated CG32579 on the first 
chromosome, CyO on the second, and TM2 on the third were crossed with female 
progeny from the A2 cross containing w and the FM7 balancer on the first chromosome 
and a copy of mutant subdued and the balancer TM6B on the third. C1 crossed males 
with w on the first chromosome, CyO and If on the second, and MKRS and the balancer 
TM6B on the third with females containing two mutated copies of CG32579 from the 
line DF1. The male progeny of this cross containing a mutated copy of CG32579 on the 
first chromosome and the balancer TM6B on the third were crossed with the female 
progeny from A3 containing mutated CG32579 and the balancer FM7 on the first 
chromosome, and mutant subdued and TM2 on the third (A4). The progeny of this cross 
were used to maintain a stock containing a mutated copy of CG32579 and the balancer 
FM7 on the first chromosome and mutant subdued and the balancer TM6B on the third. 
Females that were doubly homozygous for both mutant genes were selected for ovary 
dissection and egg chamber analysis. 
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Table 2.1 Taq polymerase thermocycler program used when performing PCR during 
mutagenesis screening. 
Taq Polymerase Thermocycler Program 
 Temperature Time Purpose 
95°C 30 seconds Initial Denaturing 
95°C 30 seconds Denature 
61.5°C 1 minute Anneal 
68°C 1 minute Elongate 
Repeat steps 2-4 35X 
68 °C 5 minutes Elongate 
4°C Forever Storage 
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Table 2.2 Phusion polymerase thermocycler program used when performing PCR during 
mutagenesis screening. 
Phusion Polymerase Thermocycler Program 
Temperature Time Purpose 
98°C 30 seconds Initial Denaturing 
98°C 10 seconds Denature 
58°C 30 seconds Anneal 
72°C 15 seconds Elongate 
Repeat steps 2-4 35X 
72 °C 5 minutes Elongate 
4°C Forever Storage 
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Table 2.3 LongAmp Taq polymerase thermocycler protocol used when performing PCR. 
LongAmp Taq Polymerase Thermocycler Program 
Temperature Time Purpose 
94°C 30 seconds Initial Denaturing 
94°C 30 seconds Denature 
58°C 60 seconds Anneal 
65°C 60 seconds Elongate 
Repeat steps 2-4 30X 
65 °C 10 minutes Elongate 
4°C Forever Storage 
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CHAPTER THREE 
Results 
3.1 CRISPR/Cas9 Editing  
The purpose of this experiment was to see whether editing CG32579 using 
CRISPR/Cas9 would introduce any mutation that would act as a null mutation in the gene 
function. Of the 200 embryos that were injected with gRNA, 40 survived, and 8 survived 
to adulthood. 3 of these flies were sterile, and the remaining 5 were used to create 
multiple descendant fly lines. Some of initial lines were screened using the procedures 
described below, and it was determined that a mutation was created in the form of a 
deletion. These experiments were conducted by Johnny Elguero and Sandy Serizier. Of 
these initial lines, 79 surviving lines were analyzed. 
3.2 Mutagenesis Screening  
In the initial mutagenesis screening, Johnny Elguero determined that the line DF1 
contained a deletion in CG32579, as evidenced a smaller sized PCR product compared to 
the wild type w1118. Of the 79 lines that I examined, the following 4 lines were 
determined to have a deletion in in the gene CG32579: DF1, DF8, DF12, and DF20. 
[Figure 3.1, Table 3.1] This confirmed that DF1 contained a deletion, as well as finding 3 
other lines in which mutagenesis had successfully taken place. These lines were 
subsequently sent to be sequenced (see section 3.3) to determine which portion of the 
sequence was deleted and whether the deletion occurred in the same location of CG32579 
in each fly line. All the fly lines starting with DF were descended from the same parent 
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fly, indicating that the CRISPR editing was successful. The remaining fly lines did not 
show any apparent deletions when DNA samples were run on gels, with their bands for 
CG32579 approximately the same length as that of w1118.  
3.3 CG32579 Sequencing 
The presence of the deletion in each of the 4 fly lines was verified using the 
methods outlined above with the Phusion polymerase. Sequencing showed that all 4 lines 
contained the same 77 base pair deletion in the first exon, in the region targeted by the 
two gRNA sequences (Figure 3.2). Therefore, we can conclude that the initial CRISPR 
editing successfully targeted the intended region of CG32579. As 77 base pairs isn’t 
evenly divisible by 3, a frameshift mutation would result when translating the mutated 
sequence, shifting the reading frame from +3 to +2. This would lead to premature 
termination of translation due to stop codons in the new reading frame, the first of which 
would start at nucleotide 548. Thus, the protein would be truncated, losing about 233 
amino acids, including the active C terminus. 
 
3.4 Heterozygosity Test 
The line PF5 exhibited two bands when its DNA was run on gel electrophoresis 
(Figure 3.2), suggesting that there may be heterozygosity at the CG32579 locus in that 
line. To test whether this genotype was widespread in the PF5 line, 20 crosses were 
created using flies from the PF5 line in order to test a greater sampling of offspring. Of 
the 20 crosses created to test this hypothesis, 4 did not produce offspring due to infertility 
 36 
and 2 did not produce offspring due to fly death. The remaining 14 were screened for 
heterozygosity using the PCR and gel electrophoresis procedure previously described. 
Analysis of the PF5 crosses did not demonstrate another appearance of the double band in 
the PCR gels, suggesting that this anomaly may be an isolated event in the fly whose 
DNA was initially analyzed.  
3.5 Slide Analysis 
 To test whether mutagenesis in CG32579 and subdued had any phenotypic effect, 
I focused on nurse cell clearance in the Drosophila ovary by mounting egg chambers on 
slides and counting the number of persisting nuclei in stage 14 egg chambers. Typically, 
stage 14 egg chambers do not have any nurse cells (seen as persisting nuclei) remaining 
(see section. 1.3.1). A high number of persisting nuclei could indicate that the 
mutagenesis in one or both CG32579 and subdued had a phenotypic effect related to 
nurse cell clearance. To examine whether a phenotypic effect in cell death was observed 
earlier in egg chamber development, midstage (stages 8-10) cell death was also 
quantified for the CG32579/subduedKO11 double mutant.  Of the slides that were 
analyzed, most did not show a persisting nuclei phenotype. The wild type control w1118 
did not exhibit persisting nuclei, as expected. Neither did the CG32579 mutants created 
via CRISPR/Cas. None of the CG32579 single mutants from the DF lines had more than 
2 persisting nuclei present in stage 14 egg chambers. Of these 5 total lines, none 
contained more than 1% of stage 14 egg chambers with persisting nuclei present. On the 
other hand, the subduedKO11 mutant line showed a more distinct mutant phenotype 
compared to the CG32579 single mutant or the wild type. The subduedKO11 mutant 
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contained up to 4 persisting nuclei in a single stage 14 egg chamber and with almost 5% 
of stage 14 egg chambers containing persisting nuclei. The CG32579/subdued double 
mutant exhibited a weak phenotype, with only about 2% of the stage 14 egg chambers 
containing persisting nuclei, and those egg chambers containing only 1 or 2 persisting 
nuclei. The double mutant was also examined for midstage egg chamber death (stages 8-
10). There was not a statistically significant difference in the frequency of midstage egg 
chamber death in either the CG32579 single mutants or the double mutant compared to 
w1118.  
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Figure 3.1 CG32579 mutagenesis screening results 
   
Agarose gel showing the results of the CG32579 mutagenesis screening. From left to 
right, the samples run were: 100 base pair ladder, w1118 (negative control), DF1 (positive 
control), DF8, DF12, DF20, LF28, MF18. Samples were run at 85V for 1 hour. The 
negative control showed the full band length of about 500 base pairs, whereas the 
positive control showed a deletion of 77 base pairs. All of the samples tested from the DF 
lines, which shared a common ancestor, exhibited the deletion. The samples from the LF 
and MF lines did not exhibit the deletion. 100 base pair ladder is shown on the left for 
scale. 
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Figure 3.2 Mutagenesis screening results showing the heterozygous genotype 
                                                
This gel demonstrates the results of gel electrophoresis run with a positive control (DF1), 
a negative control (w1118) and one of the experimental lines, PF5. This sample showed a 
heterozygous genotype for CG32579, with bands appearing at both 500 and 300 base 
pairs. This genotype was not replicated with any other sample from PF5. 100 base pair 
ladder is shown at left for scale.  
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Figure 3.3 CG32579 Mutant Alignments 
 
The alignment results for DF1 (top), DF8 (second), DF12 (third) and DF20 (bottom) 
DNA that were sequenced. Sequences from all 4 fly lines showed a deletion of 77 base 
pairs compared to the gene transcript in the same locations.  
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Figure 3.4 Stage 14 Egg Chamber Images 
 
Images of egg chambers stained with DAPI to visualize DNA from each mutant fly line 
and w1118. A) Stage 14 egg chambers from the line DF1. The top egg chamber contains 
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one persisting nurse cell nucleus (PN) (denoted by the arrow) and the bottom egg 
chamber does not contain any PN. Both egg chambers are fully surrounded by follicle 
cells (small dots). B) Stage 14 egg chamber from the line DF8 containing one PN 
(denoted by the arrow). C) Stage 14 egg chamber from the line DF12 containing zero PN. 
D) Stage 14 egg chamber from the line DF20 containing zero PN. E) Dying midstage egg 
chamber (denoted by arrow), recognizable by condensed chromatin in the nurse cell 
nuclei. F) Stage 14 egg chambers from the line subduedKO11. One egg chamber contains 
one PN (denoted by arrow) and the other egg chamber contains zero PN. G) Stage 14 egg 
chambers from the double mutant for CG32579 and subdued. The top egg chamber does 
not contain any PN and the bottom egg chamber contains several PN (denoted by arrow). 
H) Stage 14 egg chamber from w1118 (control). This egg chamber does not contain any 
PN. All images were taken under 10x magnification.  
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Figure 3.5 Stage 14 Egg Chamber Persisting Nuclei Phenotype Summary 
 
 
This graph shows the breakdown by number of persisting nuclei present in an egg 
chamber of the total number of stage 14 egg chambers observed in each fly line. draper-/-  
is used as a positive control and w1118 is used as a negative control. The vast majority of 
single mutants for CG32579 did not show a persisting nuclei phenotype in stage 14. The 
subdued mutant line subduedKO11 and the double mutant for CG32579 and subdued 
showed a weak persisting nuclei phenotype.  
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Table 3.1 Mutagenesis screening results showing whether the fly lines exhibited a 
deletion after CRISPR/Cas9 editing. 
Fly Line 
Presence of 
Deletion? 
Fly Line 
Presence 
of 
Deletion? 
Fly Line 
Presence of 
Deletion? 
 
DF1 Yes 
LF11 x 
FM7 
No nvMF37 No  
DF8 Yes 
LF12 x 
FM7 
No nvMF38 No  
DF12 Yes 
LF14 x 
FM7 
No nvMF39 No  
DF20 Yes 
LF15 x 
FM7 
No nvMF40 No  
LF1 No MF12 No nvMF42 No  
LF6 No MF13 No nvMF43 No  
LF12 No MF17 No nvMF44 No  
LF18 No MF18 No nvMF45 No  
LF19 No MF19 No nvMF46 No  
LF20 No MF21 No nvMF48 No  
LF22 No MF22 No nvMF49 No  
LF23 No MF23 No nvMF50 No  
LF24 No MF26 No PF2 No  
LF26 No MF27 No PF3 No  
LF27 No MF28 No PF5 
No; possible 
heterozygosity 
 
LF28 No MF30 No PF7 No  
LF29 No MF33 No PF27 No  
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LF31 No MF34 No PF30 No  
LF33 No MF35 No PF33 No  
LF1 x 
FM7 
No MF36 No PF40 No  
LF2 x 
FM7 
No 
MF1 x 
FM7 
No PF41 No  
LF3 x 
FM7 
No 
MF4 x 
FM7 
No PF44 No  
LF4 x 
FM7 
No  
MF6 x 
FM7 
No PF45 No  
LF5 x 
FM7 
No 
MF7 x 
FM7 
No 
PF30 x 
FM7 
No  
LF7 x 
FM7 
No 
MF9 x 
FM7 
No 
PF40 x 
FM7 
No  
LF8 x 
FM7 
No 
MF10 x 
FM7 
No SF19 No  
LF9 x 
FM7 
No 
MF11 x 
FM7 
No    
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Table 3.2 Heterozygosity test results showing whether any other PF5 progeny exhibited 
heterozygous CG32579 bands on a gel. 
Fly Cross Heterozygosity Present? 
PF5-1 No 
PF5-2 No 
PF5-3 No 
PF5-4 No 
PF5-6 No 
PF5-7 No 
PF5-10 No 
PF5-13 No 
PF5-14 No 
PF5-15 No 
PF5-16 No 
PF5-17 No 
PF5-1’ No 
PF5-7’ No 
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Table 3.3 Ovariole analysis results, performed under 10X magnification. 
Fly Line Number 
of Stage 
14 Egg 
Chambers 
Number of 
Egg 
Chambers 
with 
Persisting 
Nuclei 
Highest 
Number of 
Persisting 
Nuclei in a 
Single Egg 
Chamber 
Percentage of 
Egg Chambers 
with Persisting 
Nuclei 
Phenotype 
w1118 223 1 1 0.448% None 
DF1 271 1 1 0.369% None 
DF8 604 2 1 0.331% None 
DF12 317 1 2 0.631% None 
DF20 340 1 1 0.294% None 
subduedKO11 519 25 4 4.817% Moderate 
DF1/KO11 
Double Mutant 
577 14 2 2.426% Low 
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CHAPTER FOUR 
Discussion 
  
 The gel electrophoresis screening determined that the CRISPR/Cas9 mutagenesis 
was effective in removing a 77-nucleotide portion of CG32579 between nucleotides 217 
and 330. This mutant did not show a phenotype related to nurse cell clearance in the 
ovary, as evidenced by the lack of persisting nuclei present in stage 14 egg chambers. 
One possible, but unlikely, explanation for this observation is based on the location 
where the gene was targeted by CRISPR/Cas9. CG32579 was targeted closer to the 5’ 
end of the gene, which would impact the protein closer to the N terminus. However, the 
C terminus is the active site cleaved by caspase 8 in the human ortholog, Xkr8, to initiate 
phosphatidylserine exposure to the cell exterior and subsequent macrophage engulfment 
(Suzuki et al. 2013a). Therefore, mutagenesis which doesn’t impact the C terminus may 
have no effect on protein function. To test this idea, another round of CRISPR/Cas9 
editing targeting the 3’ end of CG32579 could be performed, which would alter the C 
terminus of the protein. If an engulfment phenotype is present in flies that have 
undergone this mutagenesis, then this would suggest that the protein activation 
mechanism is conserved in Drosophila. Since the CRISPR/Cas9 editing caused a 77 base 
pair deletion in CG32579, the resulting frameshift mutation truncated CG32579 by 233 
amino acids, including the C terminus, this explanation is improbable. 
 The double mutant for subduedKO11 and CG32579 showed a weak phenotype with 
some remaining persisting nuclei present in stage 14 egg chambers, suggesting that there 
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may be a compensatory mechanism related to phosphatidylserine exposure, possibly 
related to the functional redundancy of other Xkr or TMEM orthologs. When both 
proteins were mutated, a small proportion of stage 14 egg chambers had 4 or less 
persisting nuclei remaining, exhibiting a weak phenotype with clearance still occurring 
for the most part. Perhaps there are other Xkr8 protein orthologs in Drosophila that 
maintain phosphatidylserine exposure, just as Xkr4 and Xkr9 do in mice. (Suzuki et al. 
2014). Future experimentation could determine if this is the case by mutating other 
proteins related to phosphatidylserine scrambling, such as other TMEM orthologs 
alongside CG32579 and subdued and observing whether any phenotype related to 
engulfment is present. 
Another possibility is that PS does not serve as an important “eat me” signal in 
the ovary. Previous research found that draper is sufficient for nurse cell clearance by 
stretch follicle cells, able to bypass inactive caspase pathways (Etchegaray et al. 2012). 
Two candidate ligands for draper have been identified: the proteins Pretaporter and 
DmCaBP1 (Kuraishi et al. 2009; Okada et al. 2012). The presence of one or both of these 
proteins in nurse cells may be sufficient for draper binding and nurse cell clearance, 
rendering any failure to expose PS on the cell surface irrelevant. Other heretofore 
unidentified proteins may also serve as an “eat me” during nurse cell clearance. 
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